Prostate-specific antigen testing and prostate cancer screening. Prim Care. 2010;37:441–59.Prostate-specific Antigen Testing and Prostate Cancer Screening[J] . Bob Djavan,Elisabeth Eckersberger,Julia Finkelstein,Helen Sadri,Samir S. Taneja,Herbert Lepor.Primary Care: Clinics in Office Practice . ...
thus providing a grade C recommendation for prostate cancer screening for men in that age group. The USPSTF systematically reviewed evidence on prostate-specific antigen (PSA)-based prostate cancer screening, treatments for localized prostate cancer, and prebiopsy risk calculators...
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guidelinedoi:https://doi.org/10.1136/bmj.k3581Prostate cancer is one of the most common cancers in men and is the leading cause of cancer death in 24 countries, ranking eighth globally, sixth in high ...
Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial. Eur Urol. 2015;68(3):354-360.PubMedGoogle ScholarCrossref 33. Hugosson J, Carlsson S, Aus G, et al. Mortality results...
The prevalence of prostate cancer continues to rise. Serum PSA (Prostate Specific Antigen) can be used as a screening tool for detection of early prostate cancer However, a screening program for prostate cancer has not yet been accepted as cost-effective and long term survival benefits have not...
M McCredie, B Cox, "Prostate-specific antigen testing for prostate cancer: The case for informed consent", Medical Journal of Australia, 169, 1998, 9-10.McCredie M, Cox B. Prostate-specific antigen testing for prostate cancer: the case for informed consent. Med J Aust. 1998; 169 (1):...
Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a known genetic predisposition to PrCa due to BRCA1/2 mutations. This analysis evaluates the utility of PSA an...
Figure 2. Prostate-Specific Antigen (PSA) Screening, Prostate Biopsy, and Prostate Cancer Incidence Rates by Racial and Ethnic Group View LargeDownload Long-term nonscreening rates represent the proportion of patients without a PSA screening test in the prior 3 years. All rates were pooled across...
PSA test cost Most states have laws that require insurance plans to cover annual screening for people aged 50 and over and for those at higher risk for prostate cancer. The following groups are at higher risk: People older than 50.
Over the last 2 decades, prostate cancer (PCA) screening using the prostate specific antigen (PSA) test exposed the complexities and challenges associated with early screening for a common cancer [1]. PCA is a heterogeneous disease with a long natural history and a wide range of prognostic outc...